Sibbald, Cathryn BScPhm*; Seto, Winnie BScPhm, PharmD*†§∥; Taylor, Tracey BScPhm*‡; Saunders, E Fred MD, FRCPC‡; Doyle, John MD, FCCP‡§∥; Dupuis, L Lee MScPhm, FCSHP*‡§∥
From the *Department of Pharmacy; Divisions of †Critical Care Medicine and ‡Haematology/Oncology; §Research Institute, The Hospital for Sick Children; and ∥Faculties of Pharmacy and Medicine, University of Toronto, Toronto, Ontario, Canada.
Received for publication November 12, 2007; accepted May 13, 2008.
Sources of financial support: This study was partially supported by an unrestricted grant from Novartis Pharmaceuticals Canada, Inc., Dorval, Quebec, Canada.
Reprints: L. Lee Dupuis, MScPhm, Department of Pharmacy, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8 (e-mail: [email protected]).